Progression of lower-extremity disability in older women with diabetes: the Women's Health and Aging Study

Diabetes Care. 2003 Jan;26(1):70-5. doi: 10.2337/diacare.26.1.70.

Abstract

Objective: Older patients with diabetes are more likely to have a higher prevalence of multiple risk factors for physical disability, as a result of diabetic complications. We evaluated the pace of decline in lower-extremity function and the risk for progression of disability in older women with diabetes.

Research design and methods: We conducted a 3-year longitudinal cohort study of a random sample of 729 physically impaired older women (age > or =65 years) living in the community (Baltimore, MD). Diabetes was ascertained by standard criteria. Self-reported functional status and objective performance measures were assessed at baseline and over six semiannual follow-up visits.

Results: The baseline prevalence of diabetes was 14.4%. After adjustment for age and compared with women without diabetes, those with diabetes had an RR of 1.8 (95% CI 1.3-2.5) for incident mobility disability and 1.6 (1.2-2.1) for incident activity of daily living disability. The increased incidence of new disability associated with diabetes was paralleled by a greater decline in objective measures of lower-extremity function. Adjustment for multiple risk factors for disability did not significantly attenuate the risk for disability associated with diabetes.

Conclusions: In older patients, impaired lower-extremity function is a long-term diabetic complication. Comprehensive assessment of older diabetic patients should include a standardized evaluation of lower-extremity performance.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Activities of Daily Living
  • Aged
  • Aging
  • Cohort Studies
  • Diabetic Angiopathies / epidemiology*
  • Diabetic Angiopathies / physiopathology*
  • Disability Evaluation*
  • Disease Progression
  • Female
  • Glycated Hemoglobin / analysis
  • Humans
  • Leg
  • Longitudinal Studies
  • Multivariate Analysis
  • Risk Factors
  • Women's Health

Substances

  • Glycated Hemoglobin A